A founder effect for p47phoxTrp193Ter chronic granulomatous disease in Kavkazi Jews.

MLA

de Boer, Martin, et al. “A Founder Effect for P47phoxTrp193Ter Chronic Granulomatous Disease in Kavkazi Jews.” Blood Cells, Molecules & Diseases, vol. 55, no. 4, Dec. 2015, pp. 320–27. EBSCOhost, https://doi.org/10.1016/j.bcmd.2015.07.014.

APA

de Boer, M., Tzur, S., van Leeuwen, K., Dencher, P. C. D., Skorecki, K., Wolach, B., Gavrieli, R., Nasidze, I., Stoneking, M., Tanck, M. W. T., & Roos, D. (2015). A founder effect for p47phoxTrp193Ter chronic granulomatous disease in Kavkazi Jews. Blood Cells, Molecules & Diseases, 55(4), 320–327. https://doi.org/10.1016/j.bcmd.2015.07.014

Chicago

de Boer, Martin, Shay Tzur, Karin van Leeuwen, Paula C.D. Dencher, Karl Skorecki, Baruch Wolach, Ronit Gavrieli, et al. 2015. “A Founder Effect for P47phoxTrp193Ter Chronic Granulomatous Disease in Kavkazi Jews.” Blood Cells, Molecules & Diseases 55 (4): 320–27. doi:10.1016/j.bcmd.2015.07.014.